LTFS
REGN icon

Ladenburg Thalmann Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.8M Buy
56,130
+1,469
+3% +$494K 0.01% 936
2019
Q3 		$1.35M Buy
54,661
+50,574
+1,237% +$15M 0.01% 1035
2019
Q2 		$1.28M Sell
4,087
-989
-19% -$329K 0.01% 1051
2019
Q1 		$2.09M Buy
5,076
+121
+2% +$49.8K 0.02% 749
2018
Q4 		$1.85M Buy
4,955
+126
+3% +$46.1K 0.02% 703
2018
Q3 		$1.95M Buy
4,829
+961
+25% +$366K 0.02% 740
2018
Q2 		$1.33M Hold
3,868
– – 0.01% 899
2018
Q1 		$1.33M Buy
3,868
+189
+5% +$65.7K 0.01% 899
2017
Q4 		$1.38M Sell
3,679
-10
-0.3% -$4.05K 0.01% 874
2017
Q3 		$1.65M Sell
3,689
-782
-17% -$372K 0.02% 722
2017
Q2 		$2.2M Buy
4,471
+281
+7% +$123K 0.03% 552
2017
Q1 		$1.62M Buy
4,190
+221
+6% +$81.9K 0.02% 658
2016
Q4 		$1.46M Buy
3,969
+575
+17% +$219K 0.02% 654
2016
Q3 		$1.36M Buy
3,394
+529
+18% +$212K 0.02% 639
2016
Q2 		$1M Buy
2,865
+307
+12% +$118K 0.02% 755
2016
Q1 		$946K Sell
2,558
-296
-10% -$122K 0.02% 730
2015
Q4 		$1.55M Sell
2,854
-523
-15% -$283K 0.03% 492
2015
Q3 		$1.56M Buy
3,377
+135
+4% +$72.5K 0.03% 460
2015
Q2 		$1.65M Sell
3,242
-51
-2% -$24.9K 0.03% 485
2015
Q1 		$1.49M Buy
3,293
+875
+36% +$371K 0.03% 514
2014
Q4 		$992K Buy
2,418
+319
+15% +$125K 0.02% 604
2014
Q3 		$757K Buy
2,099
+109
+5% +$36.5K 0.02% 618
2014
Q2 		$562K Sell
1,990
-1,697
-46% -$503K 0.02% 731
2014
Q1 		$1.11M Buy
3,687
+198
+6% +$61K 0.03% 425
2013
Q4 		$960K Buy
3,489
+1,890
+118% +$544K 0.03% 454
2013
Q3 		$500K Buy
1,599
+168
+12% +$44.2K 0.02% 663
2013
Q2 		$322K Buy
+1,431
New +$333K 0.01% 788

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Ladenburg Thalmann Financial Services's REGN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Regeneron Pharmaceuticals (REGN) stake by 2.7% in Q4 2019, buying an estimated $494K and bringing the position to 56,130 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #936.

Ladenburg Thalmann Financial Services first reported a position in REGN in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.2M in Q2 2017. 703 funds tracked by Wall St. Rank hold REGN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 56,130 shares of Regeneron Pharmaceuticals worth $1.8M as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 1,469 Regeneron Pharmaceuticals shares in Q4 2019, an estimated $494K.
  • Regeneron Pharmaceuticals made up 0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #936 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Regeneron Pharmaceuticals position peaked at $2.2M in Q2 2017.
  • 703 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.